Skip to main content
. 2019 Aug 4;11(15):5463–5482. doi: 10.18632/aging.102131

Figure 6.

Figure 6

Association between CD155 and immune checkpoint markers in glioma. Correlation between CD155 and immune checkpoint markers (PD-L1, PD-L2, NR2F6, and B7-H2) in gliomas (A) and GBM (B) in Rembrandt dataset were subjected to the analysis. Correlation between CD155 and immune checkpoint markers (PD-L1, PD-L2, NR2F6, and B7-H2) in gliomas (C) and GBM (D) in TCGA were also included.